NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ImunoTera Soluções Terapêuticas

ImunoTera Soluções Terapêuticas

Private
São PauloHealthcare & Life Scienceshttps://en.imunotera.com.br/

Last Round

Accelerator

May 20, 2021

Total Funding Raised

$47,000

Company Overview

ImunoTera Soluções Terapêuticas is a biotechnology company that develops therapeutic vaccines and immunotherapies for the treatment of cancer and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

therapeutic vaccineimmunotherapybiotechnologycancer vaccinerecombinant proteindrug discoverybiotech startuptechnology licensingprecision medicineinfectious disease treatmentbiopharmaHPV vaccineR&D partnershipacademic spinoff

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ImunoTera Soluções Terapêuticas Comparables

Compare ImunoTera Soluções Terapêuticas with similar companies based on industry and business-model similarity.

ImunoTera Soluções Terapêuticas comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FUTR BIO
81%
Nykode Therapeutics
77%
Celluris
73%

ImunoTera Soluções Terapêuticas Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 20, 2021
GrantAug 26, 2020

Key People

Founding team and executive leadership

Luana Raposo de Melo

CEO

Executive Team

ImunoTera Soluções Terapêuticas Investors

Notable investors and investment history

ImunoTera Soluções Terapêuticas investors
InvestorRounds
Ministério da Ciência, Tecnologia e InovaçãoGrant
BiotechTownAccelerator
Financiadora de Estudos e ProjetosGrant
FAPESPGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2021

    $28K round led by BiotechTown

ImunoTera Soluções Terapêuticas Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ImunoTera Soluções Terapêuticas Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ImunoTera Soluções Terapêuticas's valuation, stock price, and market status.

Firmographic Details

HeadquartersSão Paulo
Employee Range6
Year Founded2016
Last FundingMay 20, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.